（Z）—3—三苯基锡基—1,1—二苯基烯丙醇的合成,晶体结构和？…

合成并表征了５种新的有机锡化合物，测定了（Ｚ）－３－三苯基锡基－１，１－二苯基烯丙醇的晶体结构。晶体属于Ｐ２１／ｎ空间群，晶胸参数ａ＝１．２３５７（３）ｎｍ，ｂ＝０．９８７４（２）ｎｍ，ｃ＝２．２０８１（２）ｎｍ，β＝９５．２３（３）°，Ｚ＝４，分子结构是以锡为中心的畸变四面体构型，双键为顺式构型，并对其性质进行了研究。     

新型氯化三苯基锡(1,4-二氢-2,3-二苯基四氮唑酮)配合物的合成及其性能

以三苯基氯化锡和二苯碳酰二肼为原料,在乙醇-钠中反应合成了一个新型的氯化三苯基锡(1,4-二氢-2,3-二苯基四氮唑酮)配合物（1）,其结构经FT-IR,元素分析和X-射线单晶衍射表征。结果表明：1（CCDC: 1 445 377）属单斜晶系,P21/c空间群,晶胞参数a=1.393 2(6) nm, b=1.097 3(5) nm, c=1.933 7(8) nm, β=110.219(9) ,V= 2.77 4(2) nm³, Z=4, Dc=1.498 g·cm^-3, F(000)=1 264, R₁=0.028 8, wR₂=0.064 6。中心Sn为五配位三角双锥构型。研究了1的荧光性质、热稳定性、电化学性质和体外抗癌活性。结果表明:1在100 ℃下较稳定; 1在400 nm(λ_ex=320 nm)处有弱荧光峰;c(1)=5 μg·mL^-1时,对HeLa细胞株增殖的抑制率为93.70%。     

一种新的分子内O→Sn络合物(Z)-1-[2-(三苯基锡基)乙烯基]-环辛醇的合成与鉴定

对分子内络合物(Z)-1-[2-(三苯基锡基)乙烯基]-环辛醇及其碘代螯合物进行了合成和鉴定,并通过X-射线四圆衍射对(Z)-1-[2-(三苯基锡基)乙烯基]-环辛醇的结构进行了表征.     

3-(四氯化锡)-丙酸甲酯阴离子的合成及晶体结构

在用酯基锡MeO2CCH2CH2SnCl3合成配合物MeO2CCH2CH2SnCl3·(2-OHC6H4CH=NC6H5)时,其配合物的甲苯溶液放置培养单晶时(放置十天以上)会发生分解生成配合物MeO2CCH2CH2SnCl4—·H+。研究了标题化合物的合成反应,用元素分析、IR、NMR对配合物进行了表征,并测定了晶体结构。为正交晶系,空间群为P2cn, a=7.852(2), b=12.236(1), c=16.952(4) ? V=1628.7?, Z=4, Dc=1.79g/cm3, F(000)= 860,m=22.2cm—1(Mo),R=0.0449, Rw=0.0382。标题化合物的空间构型为畸变的八面体构型,中心锡原子的配位数为6。     

双(三苯基锡)不饱和烃基膦酸酯的合成和性质

双(三苯基锡)不饱和烃基膦酸酯的合成和性质;生物活性     

三苯基锡(Ⅳ)哌啶氨荒酸酯的合成及结构研究

利用三苯基氯化锡和哌啶氨荒酸钠反应,合成了三苯基锡(Ⅳ)哌啶氨荒酸酯.通过元素分析、红外光谱和核磁共振氢谱对其结构进行了表征.用X-射线单晶衍射测定了该化合物的晶体结构.结果表明,化合物中锡原子呈五配位畸变三角双锥构型.     

1-[(Z)-2-(-苯基二溴化锡基)乙烯基]环戊醇的合成及晶体结构

通过１［（Ｚ）２（三苯基锡基）乙烯基］环戊醇与Ｂｒ２反应制得了新化合物１［（Ｚ）２（苯基二溴化锡基）乙烯基］环戊醇．通过元素分析、锡含量测定、ＩＲ、１ＨＮＭＲ对其进行了表征并用Ｘ射线衍射法测得了所合成化合物的晶体结构．该化合物属正交晶系，Ｐ２１２１２１空间群，晶胞参数：ａ＝０８６７５（４）ｎｍ，ｂ＝１２５２３（７）ｎｍ，ｃ＝１４００９（８）ｎｍ；Ｚ＝４，Ｖ＝１５２１９ｎｍ３，Ｄｃ＝２．３９ｃｍ３，ｕ＝２３．７２ｃｍ－１．结构分析表明，标题化合物分子为畸变的三角双锥构架，双键的两个氢取顺式结构，分子中Ｏ与Ｓｎ配位，形成五元螯合环结构     

(Z)-2-羟基-3-苯甲酰丙烯酸甲酯的合成及晶体结构

标题化合物C11H10O4的晶体结构用X-射线单晶衍射法测定。晶体属单斜晶系, P21/c空间群, 晶胞参数a = 12.136(1), b = 5.559(1), c = 14.615(2) ? b = 96.758(3), V = 979.1(3) ?, Z = 4, Mr = 206.19, Dc = 1.399 g/cm3, F(000) = 432, m(MoKa) = 0.107 mm-1。晶体结构用直接法解出, 经全矩阵最小二乘法对原子参数进行修正, 最终的偏离因子为R = 0.0453, wR = 0.0990。标题化合物形成了1个大的共轭体系, 含有1个稳定的烯醇结构。结构测定表明还存在着1个分子内氢键的结构, 它使烯醇结构更加稳定。     

三(3,5-二甲基苄基)氯化锡和四(间氰基苄基)锡的合成、晶体结构和量子化学研究

以3,5-二甲基苄基氯和间氰基苄基氯在适当的溶剂中与锡粉反应,合成了三(3,5-二甲基苄基)氯化锡(1)和四(间氰基苄基)锡(2),经X射线衍射方法测定了化合物的晶体结构。化合物1属单斜晶系,空间群为P2₁/m,晶体学参数:a=0.584 03(4) nm,b=1.966 37(14) nm,c=0.856 46 (5) nm, β=95.138(3), V=0.979 62(11) nm³,Z=2,D_c=1.735 g·cm^-3,μ(Mo Kα)=14.53 cm^-1,F(000)=524,R₁=0.043 7,wR₂=0.1232。化合物2属单斜晶系,空间群为C2/c,晶体学参数:a=1.692 21(12) nm,b=1.167 41(8) nm,c= 1.539 41(11) nm,β=116.615(10)°,V=2.718 9(3) nm³,Z=4,D_c=1.424 g·cm^-3,μ(Mo Kα)=9.67cm^-1,F(000)=1 176,R₁=0.017 5,wR₂=0.046 1;中心锡原子为畸变四面体构型。对其结构进行量子化学从头计算,探讨了配合物的稳定性、分子轨道能量以及部分前沿分子轨道的组成特征。     

三(3,5-二甲基苄基)氯化锡和四(间氰基苄基)锡的合成、晶体结构和量子化学研究

以3,5-二甲基苄基氯和间氰基苄基氯在适当的溶剂中与锡粉反应,合成了三(3,5-二甲基苄基)氯化锡(1)和四(间氰基苄基)锡(2),经X射线衍射方法测定了化合物的晶体结构。化合物1属单斜晶系,空间群为P21/m,晶体学参数:a=0.584 03(4)nm,b=1.966 37(14)nm,c=0.856 46(5)nm,β=95.138(3),V=0.979 62(11)nm3,Z=2,Dc=1.735 g·cm-3,μ(Mo Kα)=14.53 cm-1,F(000)=524,R1=0.043 7,w R2=0.123 2。化合物2属单斜晶系,空间群为C2/c,晶体学参数:a=1.692 21(12)nm,b=1.167 41(8)nm,c=1.539 41(11)nm,β=116.615(10)°,V=2.718 9(3)nm3,Z=4,Dc=1.424 g·cm-3,μ(Mo Kα)=9.67cm-1,F(000)=1 176,R1=0.017 5,w R2=0.046 1;中心锡原子为畸变四面体构型。对其结构进行量子化学从头计算,探讨了配合物的稳定性、分子轨道能量以及部分前沿分子轨道的组成特征。     

Synthesis and Crystal Structure of (Z)-Ethyl 5-(phenylamino)-3-(phenylimino)-3H-1,2-dithiole-4-carboxylate

The compound (Z)-ethyl 5-(phenylamino)-3-(phenylimino)-3H-1,2-dithiole-4-carboxylate 3 has been synthesized by the reaction of ethylacetoacetate 1 and phenylisothiocyanate 2. Its structure has been established by ¹H NMR, ¹³C NMR, infrared, mass spectra, and x-ray crystallography.      

(Z)-1-三苯基锡基-3-对氯苯基-1-丁烯-3-醇及其卤代物的合成、表征和晶体结构

在氮气保护下,3-对氯苯基-1-丁炔-3-醇与三苯基氢化锡进行游离基加成反应,获得加成物(Z)-1-三苯基锡基-3-对氯苯基-1-丁烯-3-醇(1).加成物(1)与卤素反应后,与锡原子相连的苯基被取代,得到一卤代、二卤代和混合二卤代物(2-8).通过元素分析、¹HNMR和IR表征了化合物1～8的结构,并测定了加成物(1)、一溴代物(3)和二溴代物(5)的晶体结构.在加成物(1)的晶体结构中存在一对对映体,由于分子内存在较弱的O→Sn配位作用,构成以锡原子为中心的扭曲四面体构型.在化合物3和5分子中,存在分子内O→Sn配位键,构成以锡为中心的扭曲三角双锥构型.该系列化合物分子内的O→Sn配位能力和Lewis酸性强弱的顺序为:二卤化物>一卤化物>加成物;氯代物>溴代物>碘代物.     

(Z)-1-[2-(苯基溴氯化锡基)乙烯基]-1-环己醇的晶体结构和反应机理

有机锡化合物的抗癌活性与结构的关系是人们所关注的一个重要课题[1.2].自1989年以来,我们合成了几个系列的C-Sn直接相连并在分子中存在O→Sn内配位的有机锡化合物[3]．经过抗癌活性实验,发现其中有很多种具有较高的抗癌活性．本文所报道的标题化合物分子有两种构型,迄今为止未见类似的报道．标题化合物的抗癌活性正在测试中．1实验部分1．且仪器1106型元素分析仪;锡含量用重量法分析;NicoletR。M／E四圆衍射仪．1．2标题化合物的合成（Z）－l｛2－（二苯基演化锡基）乙烯基11一环己醇（I）按照文献［"方法合成．产率80％,m．卜14…     

Synthesis and Crystal Structure of (Z)-Ethyl-4-(4-methoxy)benzylidene-2-(3,5-dimethoxypheny-tetrahydrofuran-3,3-dicarboxylate

The title compound (Z)-ethyl-4-(4-methoxy)benzylidene-2-(3,5-dimethoxyphenyl)- tetrahydrofuran-3,3-dicarboxylate has been synthesized, and its crystal structure was characterized by X-ray single-crystal diffraction. The crystal belongs to triclinic, space group P1-, with a = 8.140(3), b = 11.966(4), c = 13.771(5) α = 67.366(4), β = 85.165(5), γ = 75.806(4)°, V = 1200.1(7) 3, Z = 2, C26H30O8, Mr = 470.50, Dc = 1.302 g/cm3, F(000) = 500, λ(MoKα) = 0.71073 , μ = 0.096 mm–1, R = 0.0659 and wR = 0.1841 for 3080 observed reflections (I > 2σ(I)). As a key intermediate of HIV-1 integrase inhibitor, the synthesis and structure confirmation of the title compound are important for further studies.     

Synthesis and Crystal Structure of （Z）-Methyl-3-methoxy-2-{2-[（4-（E-3-p-tolylacryloyl）phenoxy）methyl]phenyl}acrylate

The title compound,(Z)-methyl-3-methoxy-2-{2-[(4-(E-3-p-tolylacryloyl)phenoxy)-methyl]phenyl}acrylate,was synthesized and determined by X-ray single-crystal diffraction. The crystal belongs to the triclinic system,space group P1 with a = 8.0157(8),b = 12.5748(13),c = 13.3768(14) ,α = 64.770(2),β = 75.720 (2),γ = 89.784(2)°,μ = 0.085 mm-1,Mr = 442.49,V = 1174.1(2) 3,Z = 2,Dc = 1.252 g/cm3,F(000) = 468,T = 294(2) K,R = 0.0603 and wR = 0.1498 for 2644 observed reflections with I 2σ(I). X-ray diffraction analysis reveals that the single crystal contains strong non-classical hydrogen bonds. The preliminary bioassay showed that the title compound exhibits inhibitory activity against the Pseudoperoniospora cubensis and Rhizoctonia solani at the test concentration of 200 mg/L.     

1,2,5—三甲基吡咯—3—甲叉（异丙叉）—丁二酸酐的合成与晶体结构

近年来,在光致变色材料研究领域中,人们的注意力从无机材料转移到有机材料。O-杂环俘精酸酐衍生物就是其中一类,但N-杂环俘精酸酐还没有引起人们注意。N-杂环俘精酸酐也能象O-杂环俘精酸酐一样在紫外光照射下环合成双氢吲哚的衍生物,N的给电子能力比O强,因此其双氢吲哚衍生物的吸收波长会出现红移。O-杂环俘精酸酐存     

Synthesis and Crystal Structure of the Optical Activity of （Z）-Nitromethylene Neonicotinoid Analogue

A novel (Z)-nitromethylene neonicotinoid analogue (C23H27Cl2N5O4·2H2O) (II) with optical activity has been synthesized, the structure was characterized by elemental analysis, IR and 1H NMR spectra, and the (Z)-configuration was confirmed by single-crystal X-ray diffraction. The crystal belongs to triclinic, space group P1 with a = 7.4638(3), b = 12.6232(5), c = 15.2990(6), α = 71.907(1), β = 89.397(2), γ = 80.314(1)°, V = 1349.28(9)3, Z = 2, Dc = 1.340 g/cm3, μ = 0.286 mm-1, Mr = 544.43, F(000) = 572, S = 1.056, R = 0.0801 and wR = 0.2366 for 4998 unique reflections with 3012 observed ones (I > 2σ(I)). In the crystal, the dihedral angle between the pyridine and 4-Cl-phenyl rings is 58.13°. Intermolecular O–H···O, C–H···O and C–H···Cl hydrogen bonds involving water molecules stabilize the crystal structure.     

Synthesis, Crystal Structure and Fungicidal Activity of （Z）-3,3-Dimethyl-1-（1H-1,2,4-triazol-1-yl）butan-2-one O-2-Chlorobenzyl Oxime Nitrate

The title compound has been synthesized by the reaction of 3,3-dimethyl-1-(1H-1,2,4-triazol-1-yl)butan-2-one oxime with 2-chlorobenzyl chloride, and then treated with 65～68% HNO3. Its crystal structure was determined by single-crystal X-ray diffraction. The crystal belongs to the monoclinic system, space group P21/c with a = 14.5481(8), b = 9.3351(5), c = 13.1911(7) , β = 98.9450(10)°, Z = 4, V = 1769.67(17) 3, Mr = 369.81, Dc = 1.388 g/cm3, S = 1.06, μ = 0.247 mm-1, F(000) = 776, the final R = 0.0352 and wR = 0.0960 for 3069 observed reflections (I > 2σ(I)). X-ray crystal structure presents the intramolecular N–H…O hydrogen bond. The packing is nearly parallel without π-π stacking interactions between two adjacent phenyl rings and stabilized by Van der Waals force. The preliminary bioassay shows that the title compound possesses fungicidal activity against Gibberella zeae at the dosage of 25 mg/L.     

Synthesis and Crystal Structure of 3-（1-Ethyl-1H-indole-3-carbonyl）aminopropionic Acid

3-(1-Ethyl-1H-indole-3-carbonyl)aminopropionic acid has been synthesized by alkylation of 3-(1H-indole-3-carbonyl)aminopropionic acid methyl ester with bromoethane,follo-wed by saponifying and acidating,in 89.0% yield.Its crystal structure was gotten and determined by X-ray diffraction method.The crystal is of orthorhombic,space group P212121 with a = 8.9490(12),b = 11.1010(15),c = 13.0475(18) ,V = 1296.2(3) 3,Z = 4,Dc = 1.334 g/cm3,λ = 0.71073 ,μ(MoKα) = 0.095 mm-1,Mr = 260.29 and F(000) = 552.The structure was refined to R = 0.0306 and wR = 0.1445 for 2612 observed reflections with I 2σ(I).In the crystal structure,molecules are linked to each other through hydrogen bonds of N(2)-H(2)···O(1) and O(3)-H(3)···O(1),generating a three-dimensional network.